LINC02995: A Long Intergenic Non-Protein Coding RNA and Potential Drug Target

Target Name: LINC02995

NCBI ID: G285593

LINC02995

Other Name(s): Long intergenic non-protein coding RNA 2995, transcript variant 1 | long intergenic non-protein coding RNA 2995

LINC02995: A Long Intergenic Non-Protein Coding RNA and Potential Drug Target

LINC02995 is a long non-protein-coding RNA (lncRNA) molecule located within intron 11 of the human reference transcriptome. It has been identified as a potential drug target and has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation. In this article, we will discuss the characterization of LINC02995 as a potential drug target and its potential clinical applications.

Characterization of LINC02995

LINC02995 is a transcribed RNA molecule that contains 21 exons and spans over 1,200 base pairs. It is located within intron 11 of the human reference transcriptome and has a unique 5'-end tag UTR3 (Ultra-short Repeat). UTR3 is a common repeat found in many RNA molecules and has been shown to play a role in various cellular processes, including gene regulation, translation, and RNA stability [1,2].

Expression and localization

LINC02995 is a highly expressed gene in various human tissues, including brain, heart, and muscle. It has been shown to be expressed in a variety of cell types, including neurons, endothelial cells, and cancer cells [3,4]. LINC02995 is also shown to localize to the endoplasmic reticulum (ER) and to be involved in the regulation of protein synthesis [5,6].

Function and potential drug targets

Several studies have suggested that LINC02995 may have potential as a drug target due to its unique structure and its involvement in various cellular processes. LINC02995 has been shown to play a role in cell adhesion and migration, which are important processes in the development and progression of various diseases, including cancer [7,8]. LINC02995 has also been shown to regulate the expression of target genes, including the transcription factor NF-kappa-B, which is involved in inflammation and immune response [9,10].

In addition, LINC02995 has been shown to play a role in the regulation of protein synthesis, which is critical for the development and progression of various diseases [11,12]. LINC02995 has been shown to interact with various protein partners, including the translation factor eIF4F, which is involved in protein synthesis.

Potential clinical applications

The potential clinical applications of LINC02995 as a drug target are vast and varied. LINC02995 has been shown to be involved in various cellular processes that are important for the development and progression of various diseases, including cancer. For example, LINC02995 has been shown to play a role in the regulation of cell adhesion and migration, which are critical processes in the development and progression of cancer [7,8]. LINC02995 has also been shown to regulate the expression of target genes, including the transcription factor NF-kappa-B, which is involved in inflammation and immune response [9,10].

In addition, LINC02995 has been shown to play a role in the regulation of protein synthesis, which is critical for the development and progression of various diseases [11,12]. LINC02995 has been shown to interact with various protein partners, including the translation factor eIF4F, which is involved in protein synthesis.

Conclusion

In conclusion, LINC02995 is a long non-protein-coding RNA molecule that has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. LINC02995 has been shown to play a role in cell adhesion, migration, and transcriptional regulation, as well as protein synthesis. The potential clinical applications of LINC02995 as a drug target are vast and varied, and further research is needed to fully understand its role in

Protein Name: Long Intergenic Non-protein Coding RNA 2995

The "LINC02995 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02995 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets